Myeloid transformation of B-ALL had already been described in the pre-CAR T era in patients receiving chemotherapy, particularly in those with rearrangements of the mixed lineage leukemia (MLL1, KMT2A) gene at 11q23 (38, 39). Here, KMT2A is linked to acute lymphoblastic leukemia.